So, the U.S. version of the exchange system and the UK version seem similar, although the U.S. one might have been a bit simpler than calculating meals based on black and red. In any case, what strikes me is that when MDI became standard in order to achieve good control, the exchange system was soon abandoned in favor of carb counting and calculated dosing. That, in turn, seems to have increased the burden on Type 1s in their everyday managing and micro-managing of both dosing and eating. Not surprisingly, “never getting a break” seems to be one of the top frustrations mentioned in another thread that’s active now. And never getting a break takes a real toll on people.
Now, healthcare in the U.S. has its problems where diabetes is concerned, no question. But one good thing is that the system generally doesn’t pressure you into making changes you don’t want or need. It does care about results but not so much about how you get them. Which is why I, and who knows how many other Type 1s, are using a modified version of the old exchange system and fixed dosages. It incorporates the newer insulins, primarily rapid-acting, basal and bolus doses, testing as needed, and flexibility in adjusting set doses based on current or anticipated circumstances.
It combines the benefits of the old system in terms of not having to constantly think about and work at maintaining control with the benefits of the carb/calculated dosing routine, mainly good results and the flexibility to adapt to changing circumstances and eat pretty much what and when you want, with obvious limitations. I would say it’s best suited to experienced Type 1s, not new patients or kids. And, of course, there’s a learning curve.
You wouldn’t see the powers that be embrace this approach (assuming they know of it, which I doubt) because, from their point of view, it leaves too much control in the hands of the patient and is therefore risky. The carb/calculating dosing regimen has at least the appearance of a rigorously scientific and predictable system, which is what patients and the people approving healthcare funding want to hear. The problem is, patients soon discover all the flies in the ointment and realize that the medical establishment was never the authority on living with diabetes. They are.